%PDF-1.7
%
1 0 obj
<>
endobj
85 0 obj
<>/Font<>>>/Fields 90 0 R>>
endobj
86 0 obj
<>stream
application/pdf
admin
(S28 - M\351dico Oftalmologista -...)
2010-07-27T11:09:41
PScript5.dll Version 5.2.2
2011-08-24T16:46:50-03:00
2011-08-24T16:46:50-03:00
Gnostice PDFtoolkit V2.02
uuid:c3c1a337-b780-433a-8685-d477b90d0843
uuid:baa646a5-1a8a-4e86-bbf6-96c5f0dc86f8
endstream
endobj
3 0 obj
<>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>>
endobj
35 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
50 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
55 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
60 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
65 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
70 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
75 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
115 0 obj
<>stream
q
0.12 0 0 0.12 0 0 cm
0 0 0 0.3 K
8.334 w 22.926 M
/GS0 gs
q 1 0 0 1 250.129 6638.48 cm
0 0 m
4457.101 0 l
4465.661 0 4472.661 -6.57 4472.661 -14.6 c
4472.661 -6126.843 l
4472.661 -6134.878 4465.661 -6141.453 4457.101 -6141.453 c
0 -6141.453 l
-8.555 -6141.453 -15.559 -6134.878 -15.559 -6126.843 c
-15.559 -14.6 l
-15.559 -6.57 -8.555 0 0 0 c
h
S
Q
Q
BT
0 0 0 1 k
/GS0 gs
/T1_0 12 Tf
1 0 0 1 290.1109 45.6216 Tm
(08)Tj
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 0.3 k
2455.38 496.715 47.242 6141.45 re
f*
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 0.3 k
234.57 4720.28 2243.55 17.469 re
f*
Q
BT
/T1_1 9 Tf
1 0 0 1 42.6863 773.2257 Tm
[(50.)-578(Qual)-578(das)-578(doen\347as)-578(abaixo)-578(apresenta)-578(um)-578(nemat\363deo)]TJ
0 -10.054 TD
[(subretiniano)-168(como)-167(agente)-167(etiol\363gico?)]TJ
0 -20.108 TD
[(A\))-642(Epiteliopatia)-644(pigmentada)-644(placoide)-644(multifocal)-643(posterior)]TJ
16.254 -10.054 Td
(aguda.)Tj
-16.254 -10.054 Td
[(B\))-806(Coroidite)-168(serpiginosa.)]TJ
0 -10.054 TD
[(C\))-751(S\355ndrome)-460(dos)-459(m\372ltiplos)-460(pontos)-460(brancos)-460(evanescentes)]TJ
16.254 -10.054 Td
(\(MEWDS\).)Tj
-16.254 -10.054 Td
[(D\))-751(Retinocoroidopatia)-169(de)-3836(.)]TJ
T*
[(E\))-806(Neurorretinite)-168(subaguda)-168(unilateral)-168(difusa.)]TJ
/T1_2 9 Tf
104.314 10.054 Td
(Birdshot)Tj
/T1_1 9 Tf
-104.314 -50.731 Td
[(51.)-167(Qual)-167(o)-167(padr\343o)-168(de)-167(transmiss\343o)-167(gen\351tico)-168(da)-167(coroideremia?)]TJ
0 -20.108 TD
[(A\))-806(Autoss\364mico)-167(dominante.)]TJ
0 -10.054 TD
[(B\))-806(Autoss\364mico)-167(recessivo.)]TJ
T*
[(C\))-751(Ligado)-168(ao)-167(cromossomo)-167(X.)]TJ
T*
[(D\))-751(Mitocondrial.)]TJ
T*
[(E\))-806(Ligado)-168(ao)-167(cromossomo)-149(Y)129(.)]TJ
0 -32.898 TD
[(52.)-493(Com)-493(rela\347\343o)-494(ao)-493(coloboma)-494(do)-493(disco)-493(\363ptico,)-493(\351)-493(correto)]TJ
0 -10.054 TD
[(afirmar)-167(que:)]TJ
0 -20.108 TD
[(A\))-806(a)-167(acuidade)-168(visual)-167(est\341)-167(frequentemente)-168(preservada.)]TJ
0 -10.054 TD
[(B\))-806(o)-167(campo)-167(visual)-167(mostra)-167(um)-167(defeito)-167(inferior)54(.)]TJ
T*
[(C\))-751(pode)-167(estar)-167(associado)-168(\340)-167(microftalmia)-167(e)-167(coloboma)-168(de)-167(\355ris.)]TJ
T*
[(D\))-751(pode)-515(complicar)-516(com)-515(descolamento)-516(regmatog\352nico)-516(da)]TJ
16.254 -10.054 Td
(retina.)Tj
-16.254 -10.054 Td
[(E\))-806(\340)-716(angiografia)-717(fluoresce\355nica,)-717(o)-716(coloboma)-717(se)-716(revela)]TJ
16.254 -10.054 Td
(hiperfluorescente.)Tj
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 0.3 k
234.57 5510.7 2243.55 17.469 re
f*
Q
BT
/T1_1 9 Tf
1 0 0 1 42.6863 418.4078 Tm
[(53.)-530(Qual)-530(o)-530(volume)-531(aproximado)-531(do)-530(humor)-530(v\355treo)-530(no)-530(olho)]TJ
T*
[(humano)-168(em\351trope?)]TJ
0 -20.108 TD
[(A\))-806(4.5)-167(ml.)]TJ
0 -10.054 TD
[(B\))-806(8.5)-167(ml.)]TJ
T*
[(C\))-751(10)-167(ml.)]TJ
T*
[(D\))-751(12)-167(ml.)]TJ
T*
[(E\))-806(14)-167(ml.)]TJ
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 0.3 k
234.57 3649.97 2243.55 17.469 re
f*
Q
BT
/T1_1 9 Tf
1 0 0 1 42.6863 306.6079 Tm
[(54.)-602(Qual)-602(a)-602(dose)-602(intrav\355trea)-602(da)-602(vancomicina)-603(usualmente)]TJ
T*
[(utilizada)-175(no)-174(tratamento)-174(da)-174(endoftalmite)-175(bacteriana)-175(secund\341ria)]TJ
T*
[(\340)-167(cirurgia)-168(de)-167(catarata?)]TJ
0 -20.108 TD
[(A\))-806(20)-167(mg/)-167(0.1ml.)]TJ
0 -10.054 TD
[(B\))-806(15)-167(mg/)-167(0.1)-167(ml.)]TJ
T*
[(C\))-751(10)-167(mg/)-167(0.1)-167(ml.)]TJ
T*
[(D\))-751(5)-167(mg/)-167(0.1)-167(ml.)]TJ
T*
[(E\))-806(1)-167(mg/)-167(0.1)-167(ml.)]TJ
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 0.3 k
234.57 2724.22 2243.55 17.469 re
f*
Q
BT
/T1_1 9 Tf
1 0 0 1 42.6863 182.9559 Tm
[(55.)-403(Penfigoide)-404(cicatricial)-404(\351)-403(uma)-403(doen\347a)-404(autoimune)-404(cr\364nica)]TJ
T*
[(que)-264(est\341)-264(relacionada)-265(a)-264(que)-264(tipo)-264(de)-264(hipersensibilidade)-267(\(Gell)-264(e)]TJ
T*
(Coombs\)?)Tj
0 -20.108 TD
[(A\))-806(T)37(ipo)-167(1.)]TJ
0 -10.054 TD
[(B\))-806(T)37(ipo)-167(2.)]TJ
T*
[(C\))-751(T)37(ipo)-167(3.)]TJ
T*
[(D\))-751(T)37(ipo)-167(4.)]TJ
T*
[(E\))-806(T)37(ipo)-167(5.)]TJ
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 0.3 k
234.57 1693.79 2243.55 17.469 re
f*
Q
BT
1 0 0 rg
/GS1 gs
/TT0 12 Tf
0.5762 Tc 373.222 12 Td
(\r\n)Tj
ET
q
1 0 0 1 219.125 8.7720337 cm
0 g
0 Tc /Fm0 Do
Q
endstream
endobj
117 0 obj
<>/Subtype/Form/Type/XObject>>stream
1 g
1 0 0 1 0 0 cm
220.625 10.272 m
372.6459 10.272 l
372.6459 22.368 l
220.625 22.368 l
220.625 10.272 l
f
endstream
endobj
44 0 obj
<>
endobj
15 0 obj
<>
endobj
40 0 obj
<>
endobj
83 0 obj
<>
endobj
82 0 obj
<>
endobj
41 0 obj
<>
endobj
43 0 obj
<>stream
xMWyp[!q#(\=ӡҰC@8$'OYm]Odɲ|۲%熐@wK,
lewawS扙0;+i{X l2k2axw$fO2(_+F~У?B|utoۮ-*yBM!nVKZ~g랮|xxxLյ. =܌2k
g*S
+~lJUEV z軦gpsZг(GЋ?|4I(D.^.WwA܉l<#Ӿ-s3FQKZs7-53/ 8'mUB=]n>orp&"^h`]y .9/E./fgRsӞp9qVo菩;bF*(AW?`*ʨ1)H8D8䭹BZXwm]=#?C#Tѷ~Cpb6-s×Hu`Gd֒0a_풻V)@QPnEnڐRCƴ+;yNIoC_܆Eg&L#,<8{L^SgՎKF[Ü~:%c1;
>gC&1_ɶ 5ܱ2<`&ʠp8C#jQ&[ZB&#Y@M ":ȇoӟ_`]
gmSmjo1Za[Coca}@KctΚ0˻gC#"$ XxđKCf&q".qwB/RkjAb6% }=vOM~fVԞ[pn\\vz:ixŹҸ7@G! :GzǩqM~}h 9_߄`?P>W7PhFUhX\R_ sTUxy}WW=+lqU;뚋`i~ŭ%sxOA)M#.2[pf5\AMQ)OUAN8^N}QCHUgç
ҩl*NeTJ]"PeQ3<5rZ2
--mafzZɆj.,N=AOaq_NOcr,|[CzD:W|GaYD0d!)G:
FR- ؏Ya{NTKRyeNVP
xo~ޏmy[#>'`,@npޤ(F)0d2Lf"b [OKVyrirh6_CP 3P/T/){W(S q`!l:6t4 F$vkJCMe>эɱ~
LyI/u_ )j]ӝSE\HN.NbS,܄sϋ~}ZL%2y7MJJbҧx r.o\yԬ5&Sdey,L<3!)bw(QŨ5B#7MC2bb@k/!UASArq5lP29
Qʦ!5^]bIx9Xe<[J<ҭ<#k Af}'r\2\E݄dB¶{"85F)
1ZO:=a)Wdy 5KurL։Fxj
Otr\6IyȤ;5^
>%l ƺ78>@7ƒ"_
>#foFl{J~;9
6a@U@bGZ\q5tA<7oCݷWZ=}:0@Bj:=:}X2|}s'8IGD
(zN,.Wٯ{BWŕd;7:w@+\mtRTWscXV{/ZZi'16 #Xa*4
H-UKU*Q54SCju.eUBWGB>NF0 C)E3C9))[vM-6 .zעRpOQffɅ^}-{^k~MIIٴ6ayn
us܊Uשm{Rsmw Vׅ7߂c5.
Y^4lL;c'ns
{(q.fj~_/P.C=U{5x&OERP4EG8EM[Ux;F@}KW=]
!11UF#
4L@ƗL,d~yù*
6+v^BSޑuUOl4r]>W5Nq>:KRD"+لؘ36e!9&{p9 `e
n7־خg&,M9:GG~_bA7녍T߮|Q(U*yRKU#,5̕qoDˆGˁofW.T$PcJ'Tz逑e8>t$T OI83LV$6Iqj*CUVqbX;ޠ#l#CI͉l ZyY$k`oUĵY6g96%oY[~d9Z'\
QJu~I>(&h
SSR4~;g.ŮzF98 FF-۫0]⟉2f~B|hpuFѾ!Q٢/9!a#LTWT.T_RZ00 "Vw
endstream
endobj
19 0 obj
<>
endobj
16 0 obj
<>
endobj
18 0 obj
<>stream
xzp\1Xa 삹!88@Hp˶lIնmMז{/ݖe^1`I 7Ys$Nfr3sjfww}O7`ͣRĬ㼸<^\M4}J``~G~yC
#_Uۻ-[^Z+jl kN\έO,}hgs?W'o=o̬okW}aVl
VVaKm:l)Vǖac۱'Gl9(ۈ!Vmva+؋ϰ
l{
.[݆݊ݎ}{
;1.>]Jk+`ò
^at,]Xv7&vvv [0b-X|=ns7^_>=%~;MoP7psw}t,X>м~EEEozy۫n߱䎱;w^k]Lj@hi|{ݣ\|rqѿ}_yই3Z
z',d)O\(